RNatives
Kuopio · Founded 2020
About RNatives
RNatives specializes in the field of biotechnology, focusing on the development of innovative RNA-based therapies. The company's expertise lies in RNA activation, particularly targeting VEGFA for the treatment of cardiovascular diseases. RNatives is dedicated to advancing its lead programs through rigorous research and development, aiming to offer novel therapeutic options for conditions with unmet medical needs. With a team of skilled professionals, RNatives is committed to pushing the boundaries of biotechnology to improve patient outcomes.
Company Facts
- Founded: 2020
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Funding stage: Seed
- Last round: Seed (May 2025)
- Website: https://rnatives.com
- Phone: 358 50 553 8558
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/rnatives-147268 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.